|LETTER TO EDITOR
|Year : 2020 | Volume
| Issue : 1 | Page : 67
Cost–utility analysis for chest CT versus RT-PCR for COVID-19 detection
Won Sriwijitalai1, Viroj Wiwanitkit2
1 RVT Medical Center, Bangkok, Thailand
2 Department of Tropical Medicine, Hainan Medical University, Haikou, China; Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India
|Date of Submission||24-Feb-2020|
|Date of Acceptance||16-Mar-2020|
|Date of Web Publication||05-Jun-2020|
RVT Medical Center, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Sriwijitalai W, Wiwanitkit V. Cost–utility analysis for chest CT versus RT-PCR for COVID-19 detection. Int J Prev Med 2020;11:67
COVID-19 has become an important public health problem internationally in 2020. The disease caused problems in several countries around the world. The infection can result in febrile illness with a respiratory problem. In our previous report, we have shown the limitation on the basic screening tool, temperature monitoring, for mass screening for people coming from risk areas. In clinical practice in preventive medicine, adding to the screening for risk population, the early diagnosis on suspicious cases of COVID-19 is similarly important. In general, common investigative tools include CT lung imaging and Reverse transcription polymerase chain reaction (RT-PCR). Fang et al. reported that the detections rates for initial chest CT and RT-PCR for COVID-19 detection among the clinically suspicious cases were equal to 98% and 71%, respectively. Nevertheless, there is still no study on cost and utility of tools for diagnosis.
Here, the authors performed a medical economics analysis to clarify the cost–utility of CT versus RT-PCR for COVID-19 detection. The primary data on cost are hereby referred to referencing costs for chest CT and RT-PCR by the Thai Ministry of Public Health and presented in USD. For utility, the data in the referencing publication by Fang et al. are directly referred. The number of participants in the referencing data source is equal to 51. The cost–utility analysis is done according to the standard medical economics technique. The cost–utility value is directly calculated as “cost–utility = cost/utility.” According to the study, cost, utility, and cost per utility of chest CT versus RT-PCR for COVID-19 detection are presented in [Table 1]. Based on the analysis, the cost per utility for chest CT is higher. This might imply that RT-PCR tool is still a good choice for early detection of COVID-19 in clinically suspicious cases, especially for the developing countries with limited resource.
|Table 1: Cost, utility, and cost per utility of for chest CT versus RT-PCR for COVID-19 detection|
Click here to view
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep 2020;10:8-9.
Sriwijitalai W, Wiwanitkit V. Positive screening for Wuhan novel coronavirus infection at international airport: What's the final diagnosis for positive cases. Int J Prev Med 2020;11:30. [Full text]
Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al
. Sensitivity of chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020:200432. doi: 10.1148/radiol.2020200432. [Epub ahead of print].